191 related articles for article (PubMed ID: 37992507)
21. Systems-level differential gene expression analysis reveals new genetic variants of oral cancer.
Abbas SZ; Qadir MI; Muhammad SA
Sci Rep; 2020 Sep; 10(1):14667. PubMed ID: 32887903
[TBL] [Abstract][Full Text] [Related]
22. EBV miR-BARTs and human lncRNAs: Shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer.
Torres K; Landeros N; Wichmann IA; Polakovicova I; Aguayo F; Corvalan AH
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166049. PubMed ID: 33401001
[TBL] [Abstract][Full Text] [Related]
23. Emerging role of non-coding RNA in oral cancer.
Momen-Heravi F; Bala S
Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
[TBL] [Abstract][Full Text] [Related]
24. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
25. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas.
Wang Y; Wang X; Zhang J; Sun G; Luo H; Kang C; Pu P; Jiang T; Liu N; You Y
J Neurooncol; 2012 Jan; 106(2):217-24. PubMed ID: 21842313
[TBL] [Abstract][Full Text] [Related]
28. The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer.
Taefehshokr S; Taefehshokr N; Derakhshani A; Baghbanzadeh A; Astamal RV; Safaei S; Abbasi S; Hajazimian S; Maroufi NF; Isazadeh A; Hajiasgharzadeh K; Baradaran B
Curr Mol Med; 2022; 22(3):263-273. PubMed ID: 34238182
[TBL] [Abstract][Full Text] [Related]
29. A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer.
Dar GM; Agarwal S; Kumar A; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Ali A; Mahajan B; Saluja SS; Meher R
Crit Rev Oncol Hematol; 2022 Dec; 180():103850. PubMed ID: 36261117
[TBL] [Abstract][Full Text] [Related]
30. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.
Berkel C; Cacan E
Hum Cell; 2021 May; 34(3):862-877. PubMed ID: 33576947
[TBL] [Abstract][Full Text] [Related]
31. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.
Wang M; Yu F; Wu W; Wang Y; Ding H; Qian L
Int J Biol Sci; 2018; 14(5):565-576. PubMed ID: 29805308
[TBL] [Abstract][Full Text] [Related]
33. Current trends in miRNAs and their relationship with oral squamous cell carcinoma.
Pérez-Sayáns M; Pilar GD; Barros-Angueira F; Suárez-Peñaranda JM; Fernández AC; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Jul; 41(6):433-43. PubMed ID: 22188431
[TBL] [Abstract][Full Text] [Related]
34. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.
Tanic M; Yanowsky K; Rodriguez-Antona C; Andrés R; Márquez-Rodas I; Osorio A; Benitez J; Martinez-Delgado B
PLoS One; 2012; 7(6):e38847. PubMed ID: 22701724
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.
Rishabh K; Khadilkar S; Kumar A; Kalra I; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806361
[TBL] [Abstract][Full Text] [Related]
36. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
Mjelle R; Sjursen W; Thommesen L; Sætrom P; Hofsli E
BMC Cancer; 2019 Feb; 19(1):161. PubMed ID: 30786859
[TBL] [Abstract][Full Text] [Related]
37. Meta-Analysis of miRNAs and Their Involvement as Biomarkers in Oral Cancers.
Zahra A; Rubab I; Malik S; Khan A; Khan MJ; Fatmi MQ
Biomed Res Int; 2018; 2018():8439820. PubMed ID: 29516011
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
39. Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma.
Salman A; Abdel Mageed SS; Fathi D; Elrebehy MA; Abulsoud AI; Elshaer SS; Khidr EG; Al-Noshokaty TM; Khaled R; Rizk NI; Elballal MS; Sayed GA; Abd-Elmawla MA; El Tabaa MM; Mohammed OA; Ashraf A; El-Husseiny AA; Midan HM; El-Dakroury WA; Abdel-Reheim MA; Doghish AS
Pathol Res Pract; 2023 Dec; 252():154947. PubMed ID: 37977032
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK
Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
